Brazil second in the world as infected
Coronavirus Brazil, death toll soared 120% in 2 weeks. PHOTO
In the region, 672,770 are infected today, of which 37,021 are dead. Brazil, which jumped to second place in the world rankings behind the United States, reached 330,890 infected and 21,048 dead. Peru was followed at a distance (111,698 and 3,244), while Chile (61,857 and 630) rose in third place, having overtaken Mexico (59,567 and 6,510). Then follow Ecuador (35.828 and 3.056), Colombia (18.330 and 652), Dominican Rep. (13.989 and 456), Panama (10.116 and 291), Argentina (10.649 and 433) and Bolivia (5.187 and 215).
São Paulo and Rio de Janeiro the most affected areas
Brazil recorded 1,001 new deaths from the previous day, a slightly lower number than the record 1,188 recorded on Thursday. The most affected state so far is São Paulo, a region where 46 million people live and which has recorded 76,871 cases and 5,773 deaths, which represent almost 30% of all deaths in the country. In number of deaths, behind Sao Paulo, there is Rio de Janeiro (3,657), whose capital of the same name has a mortality rate for Covid-19 of 12.7%, almost double the national average of 6.5% , as reported by the Brazilian State Institute of Geography and Statistics (IBGE) with data from the Ministry of Health. Despite the fact that most of the cases are concentrated in São Paulo and Rio de Janeiro, WHO expressed concern about the situation in the vast Amazonian northern region of the country, whose hospital infrastructure is lacking, and in Pernambuco (northeast) .
The use of chloroquine and hydroxychloroquine for therapies
Coronavirus Usa, Trump: I have been taking anti-malaria medication for ten days
Two days after Brazil approved the use of chloroquine and hydroxychloroquine for the treatment of patients with mild Covid-19, WHO also expressed its doubts about the real efficacy, considering that there is no scientific evidence stating that it is a safe and effective medicine against this disease. “Clinical trials do not support the use of this drug and it is not recommended at least until clear clinical trial results become available,” Ryan noted. Adding that investigations by the WHO regional office for the Americas, known as the Pan American Health Organization (PAHO), have not reached conclusions that would recommend it. The WHO position came on the same day a large observational study was published suggesting that antimalarial drug treatment is associated with an increase in mortality rates and an increase in cardiac arrhythmias among Covid-19 patients hospitalized in Hospital. The study, published in The Lancet, analyzed data from nearly 15,000 patients with Covid-19 who received chloroquine or its analogue, hydroxychloroquine (ingested with or without azithromycin or clarithromycin antibiotics) and data from 81,000 patients in more than 600 hospitals. .